Login
← Go Back
Zydus Lifesciences
ZYDUSLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Pankaj R Patel · MD: Sharvil P Patel · Listing date: April 28, 2000 · Employees: 24412 · Ahmedabad · http://www.zyduscadila.com
Stock Price vs Company Growth
1d
0.1%
1w
5.5%
1m
5.5%
3m
5.9%
6m
0.3%
1y
9.1%
5y
10.1%
10y
12.4%
all
17.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 941 0.1%
836
963
Company Overview
Sales
26,089 Cr
Growth: 13.2%
Profit after Tax
4,938 Cr
Growth: 0.4%
Large Cap
94,651 Cr
P/E: 19.1x
Industry P/E: 30.4x
Fundamentals
Sales (Cr) ₹ 26,089
Growth 13.2%
EBITDA 29.0%
P/S 3.6x
Dividend 1.1%
P/E 19.1x
Book Value ₹ 275
PEG Ratio 1.4x
ROE 19.0%
P/B 3.4x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
3.63 %
Kotak Flexicap Fund
2.28 %
Government Pension Fund Global
1.15 %
Iepf
0.12 %
Llp
0.07 %
Promoters
Zydus Family Trust
74.86 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
Belongs to (40 Indices) view more
Investors (135)
pankaj.r...
barclays...
icici.pr...
Followers (34)
deepak
nitin2
keerthi